ARTICLE | Clinical News
Jadenu deferasirox regulatory update
April 13, 2015 7:00 AM UTC
FDA approved Jadenu deferasirox from Novartis to treat chronic iron overload in patients ages >=10 with non-transfusion-dependent thalassemia (NTDT) syndromes and due to blood transfusions in patients...